SCHEMBL30702109

SCHEMBL30702109

Cc1ccc2cncc(N)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.41
ALOX15 P16050 2/20 0.41
CYP3A4 P08684 2/20 0.41
TP53 P04637 1/20 0.41
THRB P10828 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 3/20 0.41
HSD17B10 Q99714 2/20 0.41
LMNA P02545 2/20 0.41
NCK1 P16333 1/20 0.41
BACE1 P56817 1/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
CYP1A2 P05177 4/20 0.41
CYP2A6 P11509 3/20 0.41
ACHE P22303 6/20 0.39
BCHE P06276 4/20 0.39
GRIN1 Q05586 4/20 0.39
GRIN2A Q12879 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286180 1.00 TDP1 (0.41) TDP1ALOX15CYP3A4TP53THRB
SCHEMBL8286198 0.84 ALDH1A1 (0.46) TDP1ALOX15CYP3A4TP53THRB
SCHEMBL8404562 0.79 CYP1A2 (0.52) TDP1SMN1; SMN2ALDH1A1HSD17B10LMNA
SCHEMBL31509997 0.76 IMPDH2 (0.47) TDP1ALOX15CYP3A4TP53SMN1; SMN2
SCHEMBL30702097 0.76 BACE1 (0.41) TDP1CYP3A4ALDH1A1LMNABACE1
SCHEMBL17981072 0.76 CYP1A2 (0.41) TDP1ALDH1A1HSD17B10LMNANCK1
SCHEMBL12114723 0.76 TRPA1 (0.46) TDP1ALOX15TP53SMN1; SMN2ALDH1A1
SCHEMBL19705388 0.76 CYP1A2 (0.41) TDP1SMN1; SMN2ALDH1A1HSD17B10LMNA
SCHEMBL5987050 0.76 CYP1A2 (0.41) TDP1LMNANCK1BACE1CYP1A2
SCHEMBL29923537 0.76 CYP1A2 (0.41) TDP1ALDH1A1HSD17B10LMNANCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565574-A1 SARS-COV2 MAIN PROTEASE INHIBITORS GILEAD SCIENCES, INC. (US) 2025-06-11 EP disclosed
CN-119731159-A SARS-CoV2 main proteinase inhibitor 吉利德科学公司 2025-03-28 CN disclosed
WO-2024031089-A1 SARS-COV2 MAIN PROTEASE INHIBITORS GILEAD SCIENCES, INC. (US) 2024-02-08 WO disclosed